Sort
85,873 grants matching “alzheimers”
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology
$1,213,760Rosa Rademakers · Mayo Clinic Jacksonville · UH3 · FY2020 · NS
Resilience Mechanisms Underlying Racial/Ethnic Disparities in Alzheimerâs Disease
$1,213,752Adam M Brickman · Columbia University Health Sciences · R01 · FY2019 · AG
AN INDUCIBLE MOLECULAR MEMORY SYSTEM TO RECORD TRANSIENT STATES OF CNS CELLS
$1,213,635Robi D Mitra · Washington University · U01 · FY2017 · MH
Wisconsin Alzheimer's Disease Research Center
$1,213,492Sanjay Asthana · University Of Wisconsin-Madison · P50 · FY2013 · AG
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
$1,213,070Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2023 · AG
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain
$1,212,189Shaoqin - Gong · University Of Wisconsin-Madison · UH3 · FY2022 · NS
Clinical Core
$1,212,154Beth Snitz · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AG
The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease
$1,211,984Kelly Leigh Bolton · Washington University · R01 · FY2025 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease
$1,211,963Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Biological And Biochemical Characterization Of Sigma Receptors
$1,211,947Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2020 · DA
Assessing mitochondrial variation associated with Alzheimer's Disease
$1,211,859Jun Ding · National Institute On Aging · ZIA · FY2020 · AG
Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)
$1,211,443Hector M Gonzalez · Michigan State University · R01 · FY2016 · AG
Magnetic Resonance Spectroscopy Core Facility
$1,211,051Jun Shen · National Institute Of Mental Health · ZIC · FY2023 · MH
Genomic Convergence in Alzheimer Disease
$1,210,759Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2008 · AG
Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression
$1,210,682Christopher J Barnum · Inmune Bio, Inc. · R44 · FY2021 · MH
Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk
$1,209,751Victor Shifrin · Immunochem Therapeutics, Llc · R44 · FY2025 · AG
Core B: Alzheimer's Disease Down Syndrome Outreach Recruitment and Education (ADDORE)
$1,209,617Ann D. Cohen · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG
Single-Nuclei Multiomic Analysis of DLB Progression
$1,209,607Yoon-Seong Kim · Rutgers Biomedical And Health Sciences · RF1 · FY2025 · NS
EFFECTS OF DOCOSAHEXAENOIC ACID (DHA) IN SLOWING THE PROGRESSION OF AD (DHA)
$1,209,491Joseph F Quinn · University Of California, San Diego · U01 · FY2009 · AG
Construction and Application of Comprehensive Knowledge Graphs for Alzheimer's Disease
$1,209,382Hongtu Zhu · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AG
Prediction of Psychosis in Alzheimer Disease
$1,208,997Robert A Sweet · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AG
Core C Biospecimen
$1,208,939Bharat Thyagarajan · Washington University · U19 · FY2025 · AG
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,208,571Daniel Woo · University Of Cincinnati · U01 · FY2018 · NS
TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABI
$1,208,135Icahn School Of Medicine At Mount Sinai · N01 · FY2025 · OD
An Informatics Platform for Objectively Quantifying Electric Power Wheelchair Usage for those with Alzheimer's Disease, Alzheimer's Disease Related Dementias, and Cognitive Impairments
$1,207,722Adam Becker · Innovative Design Labs, Inc. · R44 · FY2023 · AG